BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, January 6, 2025
See today's BioWorld MedTech
Home
» Kona stakes claim in renal denervation space with WAVE IV clinical trial
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Kona stakes claim in renal denervation space with WAVE IV clinical trial
Sep. 2, 2014
By
Omar Ford
No Comments
Another company is staking its claim in developing a non-invasive approach toward treating hypertension. Kona Medical (Bellevue, Washington) is evaluating its Surround Sound Hypertension Therapy System through the WAVE IV clinical trial.
BioWorld MedTech